Lessons learned from a multi‐data source research collaboration: The mirabegron post‐authorization safety study program

• Stefan de VogelAstellas Pharma (Netherlands)
• John D. Seeger
• Alejandro AranaRTI Health Solutions
• Andrea V. MargulisRTI Health Solutions
• Lisa J. McQuayRTI Health Solutions
• Susana Perez‐GutthannRTI Health Solutions
• Jesper HallasUniversity of Southern Denmark
• Nina Sahlertz KristiansenUniversity of Southern Denmark
• Marie LinderKarolinska Institutet
• Ingvild OdsbuKarolinska Institutet
• Brandon T. SuehsHumana (United States)
• Yihua XuHumana (United States)
• Claudia UribeHumana (United States)
• Kwame AppentengAstellas Pharma (United States)
• Noah Jamie RobinsonAstellas Pharma (Netherlands)